CLCC awarded £1m NIHR funding to address threatened miscarriage
Pioneering technology to address threatened miscarriage secures £1 million funding and moves towards clinical trials • Scientists developing a pioneering device designed to address threatened miscarriage have secured £1 million in NIHR funding to begin clinical trials • Designed to deliver vital doses of progesterone, the Callavid® device stands to help over 150,000 women each …
Miscarriage Prevention: What Science Can Do And Why It’s Not Your Fault
Miscarriage. You can find lots of definitions, from the rather cold “spontaneous or unplanned expulsion of a fetus from the womb before it is able to survive independently,” to the softer “sudden loss of a pregnancy before the 20th week.” Either way, it sucks. If you have had one, I’m sorry. So why do women …
Int’l Women’s Day
A slightly belated nod to International Women’s Day (as we’ve just taken this 📸 )— but still just in time for Women’s History Month. I want to take a moment to share how incredibly grateful I am to work alongside such a brilliant, dedicated, and inspiring group of women at Calla Lily Clinical Care 🔬 It’s …
Lara Joins Springboard Women’s Health Accelerator 2025 Cohort
Our co-founder Lara Zibners MD MMEd MBA has been selected to join the Springboard Enterprises 2025 Women’s Health Cohort! Lara joins a cohort featuring 12 companies that are driving innovation in areas that differently, predominantly, or solely impact women. Over the next 3 months, the selected entrepreneurs will participate in an intensive accelerator program, working …
FemHealth Integrates Conference 25 in Manchester
☀️ The sun was shining on Manchester (apparently an unusual phenomenon) yesterday for the very first Fem Health Integrates conference. So many bright minds reunited to discuss the gaps and missed opportunities in women’s health, but mostly the future steps to change the story. 🚺 Thank you to Anastassia Bolotkova for showing me around, Jessica …
LSI Emerging Medtech Conference Day 1
The first day of the LSI Emerging Medtech conference in Dana Point, CA was superb – capped off by our well-received presentation on our Callavid® vaginal drug delivery platform. 💪 No doubt buoyed by the momentum surrounding opportunities in women’s health – there was a real buzz leading up to and following our presentation. We’re …
China & Manufacturing Patent Grants
We’ve achieved some exciting IP milestones for Calla Lily Clinical Care; making strong progress in building a robust IP strategy and IP portfolio to protect and advance our innovations in women’s health. 💥 China Patent Grant for our Drug Delivery Device 🌏 At long last, one of our vaginal drug delivery applications in China has …
Attending LSI USA 25
We’re delighted to be heading to Dana Point, CA during the LSI conference! From March 17th-21st, we’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation at one of medtech’s premier partnering events. This is an exciting opportunity to discuss new trends, potential collaborations, and meet with valued partners and industry …
The Leak Stops Here: Calla Lily Reinventing Drug Delivery for Women
University Science Center in Philadelphia, Pennsylvania highlights their CRP alum Lara in their latest Insight article: Around 23 million women worldwide experience miscarriages 𝘦𝘷𝘦𝘳𝘺 𝘺𝘦𝘢𝘳. While progesterone can reduce the risk, effective delivery remains a challenge. Frustrated with the existing, ineffective methods available, CRP alum Lara Zibners set out to create a better solution in …
Film Industry Network: Kaylie Mings discusses Women’s Health at SXSW
To coincide with the launch of this year’s SXSW, the Film Industry Network discussing women’s health with Texas native and product development engineer Kaylie Mings. Interview here: https://filmindustry.network/product-development-engineer-kaylie-mings-discusses-womens-health-at-sxsw/40570